Method Development of Swab Sampling for Cleaning Validation of a Residual Active Pharmaceutical Ingredient
A swab-sampling method was developed for cleaning validation of a residual active pharmaceutical ingredient in samples collected after cleaning the sampling suite. A summary of the strategies and results of the method development is presented.
Articles in this issue
An Overview of the Effect of Moisture on Compaction and Compression
Method Development of Swab Sampling for Cleaning Validation of a Residual Active Pharmaceutical Ingredient
The Pipeline Crisis
The Outsourcing Advantages in Formulation Development
Drug Safety and Access Top Policy Concerns for 2005
Comparison of EP "Heavy Metals" Test with USP "Conductivity" Test
Patheon Places Big Bet with Mova Acquisition
Superdisintegrants for Solid Dispersion To Produce Rapidly Disintegrating Tenoxicam Tablets via Camphor Sublimation
January 2005
In the Spotlight-January 2005
Recent Videos
Related Content
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024Podcast
In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
